M102AI : Rheumatoid Arthritis

Rheumatoid Arthritis(RA) is an autoimmune disorder that is characterized by severe inflammation in the joints, the formation of a pannus, bone loss, and deformation of the joints. Many patients experience recurrences and are refractory to existing treatments. Our technology provides unique working mechanisms of “Pan-therapeutics” that simultaneously suppress various proinflammatory cytokines and chemokines as well as immune cells, synoviocytes, and osteoclasts from excessive activation, allowing us to treat patients who are resistant to current therapeutics such as anti-TNF-α biologics.